We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?

    Kristofer Andréasson, Viggo Hamberg, ... Gunilla Westergren-Thorsson in Nature Reviews Rheumatology
    Article 21 August 2023
  2. A case of progressive multifocal leukoencephalopathy in a post-kidney transplant patient with improvement after discontinuation of immunosuppressive drugs and combination therapy with mefloquine and mirtazapine

    Background

    Progressive multifocal leukoencephalopathy is a rare disease, but the prognosis is very poor, especially in the immunosuppressed state with...

    Neri Sone, Hiroki Nishiwaki, ... Fumihiko Koiwa in Renal Replacement Therapy
    Article Open access 19 December 2023
  3. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives

    Glioblastoma (GBM), the predominant and primary malignant intracranial tumor, poses a formidable challenge due to its immunosuppressive...

    Hao Lin, Chaxian Liu, ... Ying Mao in Journal of Hematology & Oncology
    Article Open access 08 May 2024
  4. Immunosuppressive drugs

    Article 09 October 2021
  5. Identification of cytokine-predominant immunosuppressive class and prognostic risk signatures in glioma

    Purpose

    The advent of immune checkpoint blockade (ICB) therapies this year has changed the way glioblastoma (GBM) is treated. Meanwhile, some patients...

    Ziyue Tian, Zhongyi Yang, ... Weimin Zhao in Journal of Cancer Research and Clinical Oncology
    Article 21 July 2023
  6. Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines

    Hepatitis B (HBV) reactivation (HBVr) is a potentially fatal complication in patients with past HBV exposure receiving immunosuppressive therapy....

    Samuel Etienne, Jürg Vosbeck, ... Michael Osthoff in Journal of General Internal Medicine
    Article Open access 22 September 2022
  7. Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project)

    Background

    Very scanty evidence is available on factors influencing the choice of immunosuppressive drug therapy after kidney transplantation.

    ...
    Alessandro C. Rosa, Marco Finocchietti, ... Ugo Moretti in BMC Nephrology
    Article Open access 27 October 2023
  8. How immunosuppressive drugs may directly target podocytes in glomerular diseases

    Podocytes are the direct target of immunologic injury in many immune-mediated glomerular diseases, leading to proteinuria and subsequent kidney...

    Maurizio Salvadori, Aris Tsalouchos in Pediatric Nephrology
    Article 09 July 2021
  9. Shifting cold to hot tumors by nanoparticle-loaded drugs and products

    Cold tumors lack antitumor immunity and are resistant to therapy, representing a major challenge in cancer medicine. Because of the immunosuppressive...

    Irfan Ahmad, Kamil K. Atiyah Altameemi, ... Ahmed huseen Redhee in Clinical and Translational Oncology
    Article 26 June 2024
  10. Plasmablastic lymphoma occurring in ulcerative colitis during treatment with immunosuppressive therapy

    A 53-year-old man who had a history of ulcerative colitis (UC) for 2 years underwent colonoscopy as regular follow-up. The results showed an elevated...

    Hideharu Ogiyama, Yoko Murayama, ... Hiroyasu Iishi in Clinical Journal of Gastroenterology
    Article 06 January 2023
  11. Long-term immunosuppressive treatment is not associated with worse outcome in patients hospitalized in the intensive care unit for septic shock: the PACIFIC study

    Background

    Except in a few retrospective studies mainly including patients under chemotherapy, information regarding the impact of immunosuppressive...

    Julien Vaidie, Edwige Peju, ... Bruno François in Critical Care
    Article Open access 02 September 2023
  12. Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections

    The objective of this study is to provide practical recommendations on the management of pediatric patients with immune-mediated rheumatic diseases...

    Daniel Clemente, Esmeralda Núñez Cuadros, ... Cristina Calvo in European Journal of Pediatrics
    Article Open access 04 December 2023
  13. FBP1 is a potential prognostic biomarker and correlated with tumor immunosuppressive microenvironment in glioblastoma

    Hypoxia has been shown to contribute to tumor immunosuppressive microenvironment and is an effective prognostic indicator. This study aimed to screen...

    Hu Sun, Hui Zhang, ... Wei Song in Neurosurgical Review
    Article 29 July 2023
  14. DDOST is associated with tumor immunosuppressive microenvironment in cervical cancer

    Evidence has revealed that DDOST plays an important role in cancer development and progression. However, there are no reports on functions of DDOST...

    Jie Mei, Liuliu Pan, ... Danhan Wang in Discover Oncology
    Article Open access 09 March 2024
  15. Effect of immunosuppressive medication on postoperative complications following abdominal surgery in Crohn’s disease patients

    Background

    Immunosuppressants represent an effective pharmacological treatment for the remission and management of Crohn’s disease (CD); however, it...

    Saleh Lahes, Celine Fischer, ... Matthias Glanemann in International Journal of Colorectal Disease
    Article Open access 28 November 2022
  16. Outcomes of Escalating Immunosuppressive Treatments for Recalcitrant Noninfectious Posterior Scleritis

    Introduction

    This article aimed to summarize the outcomes of escalating immunosuppressive treatments for patients with recalcitrant noninfectious...

    Yuan Pan, Yu-** Chen, ... Dan Liang in Ophthalmology and Therapy
    Article Open access 12 October 2022
  17. Immunomodulatory and immunosuppressive drug protocols in the treatment of canine primary immune thrombocytopenia, a sco** review

    Primary immune thrombocytopenia (ITP) is a cause of severe thrombocytopenia in dogs. Immunosuppressive corticosteroid drugs are frequently used in...

    Peter Spanner Kristiansen, Lise Nikolic Nielsen in Acta Veterinaria Scandinavica
    Article Open access 27 December 2021
Did you find what you were looking for? Share feedback.